Aditxt, Inc. Depreciation
Aditxt, Inc. (ADTX) reported Depreciation of $47.88 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-05-20
- Aditxt, Inc. depreciation for the quarter ending 2026-03-31 was $47.88K, a 30.05% decline year-over-year.
- Aditxt, Inc. depreciation for the quarter ending 2025-12-31 was $66.81K, a 59.64% decline year-over-year.
- Aditxt, Inc. depreciation for the quarter ending 2025-09-30 was $66.70K, a 55.01% decline year-over-year.
- Aditxt, Inc. depreciation for the quarter ending 2025-06-30 was $67.05K, a 57.35% decline year-over-year.
- Aditxt, Inc. depreciation for fiscal 2025 was $269.27K, a 56.14% decline from fiscal 2024.
- Aditxt, Inc. depreciation for fiscal 2024 was $613.92K, a 41.12% increase from fiscal 2023.
- Aditxt, Inc. depreciation for fiscal 2023 was $435.03K, a 1.41% increase from fiscal 2022.
- Aditxt, Inc. depreciation for fiscal 2022 was $428.98K, a 16.18% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-03-31 | $47.88K 10-Q · filed 2026-05-20 | $114.69K derived: sum of 2 quarters · filed 2026-05-20 | $181.39K derived: sum of 3 quarters · filed 2026-05-20 | $248.43K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-12-31 | $66.81K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $133.50K derived: sum of 2 quarters · filed 2026-03-31 | $200.55K derived: sum of 3 quarters · filed 2026-03-31 | $269.27K 10-K · filed 2026-03-31 |
| 2025-09-30 | $66.70K 10-Q · filed 2025-11-18 | $133.75K derived: sum of 2 quarters · filed 2025-11-18 | $202.46K 10-Q · filed 2025-11-18 | $367.73K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-06-30 | $67.05K 10-Q · filed 2025-08-14 | $135.50K 10-Q · filed 2025-08-14 | $301.03K derived: sum of 3 quarters · filed 2026-05-20 | $449.29K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-03-31 | $68.45K 10-Q · filed 2026-05-20 | $233.99K derived: sum of 2 quarters · filed 2026-05-20 | $382.24K derived: sum of 3 quarters · filed 2026-05-20 | $539.44K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $165.53K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $313.79K derived: sum of 2 quarters · filed 2026-03-31 | $470.99K derived: sum of 3 quarters · filed 2026-03-31 | $613.92K 10-K · filed 2026-03-31 |
| 2024-09-30 | $148.26K 10-Q · filed 2025-11-18 | $305.45K derived: sum of 2 quarters · filed 2025-11-18 | $448.38K 10-Q · filed 2025-11-18 | $554.00K derived: sum of 4 quarters · filed 2025-11-18 |
| 2024-06-30 | $157.20K 10-Q · filed 2025-08-14 | $300.13K 10-Q · filed 2025-08-14 | $405.75K derived: sum of 3 quarters · filed 2025-08-14 | $515.36K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $142.93K 10-Q · filed 2025-05-15 | $248.55K derived: sum of 2 quarters · filed 2025-05-15 | $358.16K derived: sum of 3 quarters · filed 2025-05-15 | $468.06K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $105.62K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $215.23K derived: sum of 2 quarters · filed 2025-03-31 | $325.13K derived: sum of 3 quarters · filed 2025-03-31 | $435.03K 10-K · filed 2025-03-31 |
| 2023-09-30 | $109.61K 10-Q · filed 2024-11-18 | $219.51K derived: sum of 2 quarters · filed 2024-11-18 | $329.41K 10-Q · filed 2024-11-18 | $461.70K derived: sum of 4 quarters · filed 2024-11-18 |
| 2023-06-30 | $109.90K 10-Q · filed 2024-08-19 | $219.80K 10-Q · filed 2024-08-19 | $352.09K derived: sum of 3 quarters · filed 2024-08-19 | $452.07K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $109.90K 10-Q · filed 2024-05-20 | $242.19K derived: sum of 2 quarters · filed 2024-05-20 | $342.17K derived: sum of 3 quarters · filed 2024-05-20 | $442.02K derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-12-31 | $132.29K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $232.27K derived: sum of 2 quarters · filed 2024-04-16 | $332.12K derived: sum of 3 quarters · filed 2024-04-16 | $428.98K 10-K · filed 2024-04-16 |
| 2022-09-30 | $99.98K 10-Q · filed 2023-11-14 | $199.83K derived: sum of 2 quarters · filed 2023-11-14 | $296.69K 10-Q · filed 2023-11-14 | $399.54K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $99.85K 10-Q · filed 2023-08-14 | $196.70K 10-Q · filed 2023-08-14 | $299.56K derived: sum of 3 quarters · filed 2023-08-14 | $399.41K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $96.85K 10-Q · filed 2023-05-15 | $199.70K derived: sum of 2 quarters · filed 2023-05-15 | $299.56K derived: sum of 3 quarters · filed 2023-05-15 | $399.85K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $102.85K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $202.71K derived: sum of 2 quarters · filed 2023-04-17 | $302.99K derived: sum of 3 quarters · filed 2023-04-17 | $369.24K 10-K · filed 2023-04-17 |
| 2021-09-30 | $99.86K 10-Q · filed 2021-11-15 | $200.14K derived: sum of 2 quarters · filed 2022-08-15 | $266.38K 10-Q · filed 2022-11-14 | $281.36K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-06-30 | $100.29K 10-Q · filed 2022-08-15 | $166.53K 10-Q · filed 2022-08-15 | $181.51K derived: sum of 3 quarters · filed 2022-08-15 | $184.30K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $66.24K 10-Q · filed 2022-05-16 | $81.22K derived: sum of 2 quarters · filed 2022-05-16 | $84.02K derived: sum of 3 quarters · filed 2022-05-16 | $84.02K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $14.98K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $17.77K derived: sum of 2 quarters · filed 2022-03-31 | $17.77K derived: sum of 3 quarters · filed 2022-03-31 | $17.77K 10-K · filed 2022-03-31 |
| 2020-09-30 | $2.80K 10-Q · filed 2021-11-15 | $2.80K derived: sum of 2 quarters · filed 2021-11-15 | $2.80K 10-Q · filed 2021-11-15 | $2.80K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2021-08-12 | $0.00 derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-12 | $0.00 derived: sum of 2 quarters · filed 2021-05-12 | $0.00 derived: sum of 3 quarters · filed 2021-05-12 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 10-K · filed 2021-03-25 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |